These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11591358)
21. Evidence for benefits of perindopril in hypertension and its complications. Laurent S Am J Hypertens; 2005 Sep; 18(9 Pt 2):155S-162S. PubMed ID: 16125052 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. Toblli JE; Cao G; DeRosa G; Di Gennaro F; Forcada P Am J Hypertens; 2004 Feb; 17(2):172-80. PubMed ID: 14751661 [TBL] [Abstract][Full Text] [Related]
23. Dosage considerations with perindopril for systemic hypertension. Sica DA Am J Cardiol; 2001 Oct; 88(7A):13i-18i. PubMed ID: 11591356 [TBL] [Abstract][Full Text] [Related]
25. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy]. Agabiti-Rosei E Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883 [TBL] [Abstract][Full Text] [Related]
26. Regression of media-to-lumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensin-converting enzyme inhibitor-based regimen in hypertensive patients. Sihm I; Schroeder AP; Aalkjaer C; Holm M; Mørn B; Mulvany M; Thygesen K; Lederballe O Am J Cardiol; 1995 Nov; 76(15):38E-40E. PubMed ID: 7484887 [TBL] [Abstract][Full Text] [Related]
27. Specific properties and effect of perindopril in controlling the renin-angiotensin system. Ferrari R; Pasanisi G; Notarstefano P; Campo G; Gardini E; Ceconi C Am J Hypertens; 2005 Sep; 18(9 Pt 2):142S-154S. PubMed ID: 16125051 [TBL] [Abstract][Full Text] [Related]
28. ACE inhibition in hypertension: focus on perindopril. Cockcroft JR Am J Cardiovasc Drugs; 2007; 7(5):303-17. PubMed ID: 17953470 [TBL] [Abstract][Full Text] [Related]
29. Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptor. Du Q; Wu J; Wang H; Wang X; Xu L; Zhang Z; Liu J; Zhang J; Chen J; Hakonarson H; Hu A; Zhang L BMC Cardiovasc Disord; 2013 Oct; 13():94. PubMed ID: 24175973 [TBL] [Abstract][Full Text] [Related]
30. Role of perindopril in the prevention of stroke. Papadopoulos DP; Votteas V Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):283-9. PubMed ID: 18221093 [TBL] [Abstract][Full Text] [Related]
31. Perindopril reverses myocyte remodeling in the hypertensive heart. Onodera T; Okazaki F; Miyazaki H; Minami S; Ito T; Seki S; Taniguchi M; Taniguchi I; Mochizuki S Hypertens Res; 2002 Jan; 25(1):85-90. PubMed ID: 11924731 [TBL] [Abstract][Full Text] [Related]
32. Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia. Sirenko Y; Radchenko G; High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):85-93. PubMed ID: 28150140 [TBL] [Abstract][Full Text] [Related]
33. Perindopril: a review of its use in patients with or at risk of developing coronary artery disease. Curran MP; McCormack PL; Simpson D Drugs; 2006; 66(2):235-55. PubMed ID: 16451098 [TBL] [Abstract][Full Text] [Related]
34. Perindopril: the reasonable choice in patients with coronary artery disease. Cockcroft JR Int J Clin Pract; 2005 May; 59(5):600-4. PubMed ID: 15857358 [TBL] [Abstract][Full Text] [Related]
35. [Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction]. Zhang YL; Zhou SX; Wang MH; Wang JF Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1584-8. PubMed ID: 17121705 [TBL] [Abstract][Full Text] [Related]
36. Perindopril effects on ambulatory blood pressure: relation to sympathetic nervous activity in subjects with diabetic nephropathy. Yasuda G; Hasegawa K; Kuji T; Ogawa N; Shimura G; Umemura S; Tochikubo O Am J Hypertens; 2004 Jan; 17(1):14-20. PubMed ID: 14700506 [TBL] [Abstract][Full Text] [Related]
37. [Perindopril arginin: novel drug form of a well known Angiotensin converting enzyme inhibitor]. Leonova MV Kardiologiia; 2008; 48(10):65-70. PubMed ID: 18991838 [No Abstract] [Full Text] [Related]
38. [Daily blood pressure profiles and endothelial functions during long-term treatment of arterial hypertension with angiotensin-converting enzyme inhibitors]. Simonenko VB; Fisun AIa; Mikhaĭlov AA; Kuroedov AV; Brizhan MV; Butikov VP; Tsokolov AV Klin Med (Mosk); 2004; 82(7):48-55. PubMed ID: 15449776 [TBL] [Abstract][Full Text] [Related]
39. Ongoing trials of angiotensin-converting enzyme inhibition: what they can tell us. Chalmers JP Am J Hypertens; 2001 Aug; 14(8 Pt 2):270S-275S. PubMed ID: 11497208 [TBL] [Abstract][Full Text] [Related]
40. The blood vessel as a target organ in hypertension: protective effect of perindopril. Plante GE Can J Cardiol; 1994 Nov; 10 Suppl D():25D-29D. PubMed ID: 7954036 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]